Disease progression in a patient with nonalcoholic steatohepatitis.
暂无分享,去创建一个
Ding‐Shinn Chen | Pei-Jer Chen | J. Kao | Chun-Jen Liu | C. Shun | P. Tseng | Pei‐Jer Chen
[1] Yang-Chu Lin,et al. Hepatic Histopathology of Morbid Obesity: Concurrence of Other Forms of Chronic Liver Disease , 2006, Obesity surgery.
[2] D. Pei,et al. The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians , 2005, International journal of clinical practice.
[3] Y. Jeng,et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. , 2005, Journal of hepatology.
[4] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[5] C. Day. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. , 2005, Gastroenterology.
[6] Y. Jeng,et al. Influence of Metabolic Syndrome, Viral Genotype and Antiviral Therapy on Superimposed Fatty Liver Disease in Chronic Hepatitis C , 2005, Antiviral therapy.
[7] J. Sung,et al. Histological progression of non‐alcoholic fatty liver disease in Chinese patients , 2005, Alimentary pharmacology & therapeutics.
[8] F. Chan,et al. Clinical and histological features of non‐alcoholic fatty liver disease in Hong Kong Chinese , 2004, Alimentary pharmacology & therapeutics.
[9] J. Dixon,et al. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss , 2004, Hepatology.
[10] P Christoffersen,et al. Long term prognosis of fatty liver: risk of chronic liver disease and death , 2004, Gut.
[11] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.
[12] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[13] S. Lai,et al. Epidemiology of Fatty Liver in a Hospital-based Study in Taiwan , 2002, Southern medical journal.
[14] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[15] F. Brancati,et al. Nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[16] P. Angulo,et al. Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.
[17] G. Marchesini,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.
[18] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[19] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[20] Z. Younossi,et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.
[21] H. Hsu,et al. Ultrasonography in the diagnosis of benign diffuse parenchymal liver diseases: a prospective study. , 1988, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association.
[22] G. Farrell,et al. LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis , 2006 .
[23] S. Sanderson,et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. , 2005, Journal of hepatology.
[24] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.